| Zeit | Aktuelle Nachrichten
| | Leser | Medien |
|---|
| 25.05.
| Human Genome Shareholders Should Not Get Greedy | | 10 | Seeking Alpha |
| 24.05.
| A Forward Look, the Year Ahead - Featured Research on Jazz Pharmaceuticals and Human Genome Sciences | | 29 | MarketWire |
| HONG KONG -- (Marketwire) -- 05/24/12 -- Today, www.BollingerReport.com introduced featured coverage of Jazz Pharmaceuticals (NASDAQ: JAZZ) and Human Genome Sciences (NASDAQ: HGSI). Full research...
Mehr lesen zu:
A Forward Look, the Year Ahead - Featured Research on Jazz Pharmaceuticals and Human Genome Sciences | |
| 24.05.
| Downgrade Alert for Human Genome Sciences | | 14 | SmarTrend |
| 23.05.
| GlaxoSmithKline Amends Offer In Response To Human Genome Poison Pill | | 79 | AFX News |
| LONDON (dpa-AFX) - GlaxoSmithKline plc (GSK, GSK.L) Wednesday amended the
conditions of its unsolicited tender offer to acquire Human Genome Sciences
(HGSI) for $13.00 per share.The move...
Mehr lesen zu:
GlaxoSmithKline Amends Offer In Response To Human Genome Poison Pill | |
| 23.05.
| DealBook: Glaxo Amends Its $2.59 Billion Bid for Human Genome Sciences | | 14 | New York Times |
| 21.05.
| Life Technologies Foundation Announces Lead Sponsorship of Smithsonian Exhibit to Celebrate 10th Anniversary of the Human Genome Project's Completion | | 20 | PR Newswire |
| CARLSBAD, Calif., May 21, 2012 /PRNewswire/ --The Life Technologies Foundation, the philanthropic arm of Life Technologies Corporation (NASDAQ: LIFE), today announced it is the lead sponsor of a planned...
Mehr lesen zu:
Life Technologies Foundation Announces Lead Sponsorship of Smithsonian Exhibit to Celebrate 10th Anniversary of the Human Genome Project's Completion | |
| 18.05.
| GlaxoSmithKline continues pursuit of Human Genome Sciences despite 'poison pill' | | 25 | Yahoo-CAN |
| 18.05.
| Glaxo undeterred by Human Genome 'poison pill' | | 11 | Yahoo-USA |
| 18.05.
| Morning News: Bonität Griechenlands, Moody's Rating spanische Banken, Metall Tarifstreit, US Solarimporte, Coty, Facebook, Human Genome Sciences, HP, Ergo | | 5 | be24.at |
| 17.05.
| Human Genome will mit Weissem Ritter Übernahme durch GSK abwenden | | 40 | boerse-express.com |
| 17.05.
| Human Genome will mit 'Weißem Ritter' Übernahme durch GSK abwenden | | 161 | dpa-AFX |
| Das Biotech-Unternehmen Human Genome
Sciences will mit einem "Weißen Ritter" die
feindliche Übernahme durch den britischen Pharmakonzern
GlaxoSmithKline (GSK) abwenden. Wie das in
Rockville...
Mehr lesen zu:
Human Genome will mit 'Weißem Ritter' Übernahme durch GSK abwenden | |
| 17.05.
| ROUNDUP: GlaxoSmithKline To Proceed With Tender Offer To Acquire Human Genome | | 55 | AFX News |
| LONDON (dpa-AFX) - GlaxoSmithKline plc (GSK, GSK.L) Thursday reiterated that
its $13.00 per share offer to acquire Human Genome Sciences (HGSI) represents
'full and fair value' and is in...
Mehr lesen zu:
ROUNDUP: GlaxoSmithKline To Proceed With Tender Offer To Acquire Human Genome | |
| 17.05.
| GSK Says It Continues To Proceed With Human Genome Sciences Tender Offer | | 54 | AFX News |
| LONDON (dpa-AFX) - GlaxoSmithKline plc (GSK, GSK.L) commented on Human
Genome Sciences (HGSI) Board of Directors' decision to recommend against GSK's
tender offer to acquire all of the outstanding...
Mehr lesen zu:
GSK Says It Continues To Proceed With Human Genome Sciences Tender Offer | |
| 17.05.
| Glaxo (GSK) Comments on Human Genome (HGSI) Bid Rejection; Will Continue with $13/Share Tender | | 6 | StreetInsider.com |
| 17.05.
| GlaxoSmithKline And Human Genome Science: Don't Bite The Hand That Feeds You | | 4 | Seeking Alpha |
| 17.05.
| Human Genome Looks to Anyone but GlaxoSmithKline | | 8 | Benzinga.com |
| 17.05.
| DealBook: Human Genome Sciences Adopts Poison Pill to Thwart Glaxo Takeover | | 3 | New York Times |
| 17.05.
| Human Genome board adopts 'poison pill' antitakeover plan, rejects GlaxoSmithKline $2.6B bid | | 2 | Yahoo-CAN |
| 17.05.
| Human Genome board adopts 'poison pill' measure | | 3 | Yahoo-USA |
| 17.05.
| Human Genome Sciences Urges Stockholders Reject GlaxoSmithKline's Tender Offer | | 58 | AFX News |
| LONDON (dpa-AFX) - Human Genome Sciences, Inc. (HGSI) said its Board of
Directors, after careful review and consideration with the assistance of the
company's management and financial and...
Mehr lesen zu:
Human Genome Sciences Urges Stockholders Reject GlaxoSmithKline's Tender Offer | |
